Skip to content

Clinical trials

Tourette Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tourette Syndrome Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20121
20133
20141
20161
20171
20183
20192
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status4
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Cologne4
Emalex Biosciences Inc.3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Abide Therapeutics2
Boehringer Ingelheim2
Hannover Medical School2
Max Planck Institute for Human Cognitive and Brain Sciences2
Neurothera Labs Inc.2
Noema Pharma AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tourette Syndrome21
Tic Disorders5
Tics5
Basal Ganglia Diseases1
Brain Diseases1
Central Nervous System Diseases1
Mental Disorders1
Movement Disorders1

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.